Minocap Injection

About Minocap 1 gm/5ml Injection

Minocap Injection is a brand of aminocaproic acid, an anti-fibrinolytic medicine given to reduce heavy bleeding, particularly after surgery where a lot of blood loss is expected. It is supplied as a 1 gm/5ml injection.

There are 3 brands of Aminocaproic Acid listed in Bangladesh. The lowest listed price is Hemolysin 1 gm/5ml Injection at ৳ 1 per unit.

What is Minocap 1 gm/5ml Injection?

Minocap Injection contains aminocaproic acid, an anti-fibrinolytic medicine. It works by slowing down the body's natural clot-breaking process, which helps reduce blood loss. It is used for excessive bleeding after operations, including procedures where a large amount of bleeding is expected, such as heart surgery. The medicine can be given by mouth or by injection into a vein. Aminocaproic acid is cleared from the body fairly quickly, so repeat administration is usually needed. Because of this, the doctor decides the dose and how often it is given, and adjusts treatment to each patient's condition and how severe the bleeding is.

Uses of Minocap

Minocap Injection is used to control excessive bleeding after surgical procedures, especially operations in which heavy bleeding is expected, such as cardiac surgery. It helps reduce blood loss by limiting the breakdown of blood clots. It may be given by injection into a vein when a quick effect is needed, or by mouth in other situations. The doctor decides how it is given and how long treatment continues.

How to use Minocap

Minocap Injection is given by a healthcare professional, usually into a vein, sometimes as a slow injection. It is not meant to be used at home by the patient. How much is given and how often depends on the individual case and the severity of the bleeding, so the doctor sets the dose and course. Tell the doctor about any other medicines you take before treatment starts.

Side effects of Minocap

Some people may notice mild muscle pain or weakness, headache, tiredness, nausea, vomiting, stomach pain or diarrhoea. A stuffy nose, watery eyes, ringing in the ears, vision problems, a mild skin rash, or a reduced amount of semen in men may also occur. Anyone who develops unusual or troublesome symptoms during or after treatment should tell the doctor or nurse looking after them.

Safety and precautions

Minocap Injection is not used when there is an active clotting problem inside the blood vessels, and the cause of bleeding must be checked before it is given. Its safety and effectiveness in younger patients have not been established. In pregnancy it should be used only when clearly needed, and it is not known whether it passes into breast milk, so pregnant or breastfeeding women should speak to the doctor first. Anyone with a history of clotting problems, kidney concerns or other medical conditions should also ask the doctor before treatment.

Frequently asked questions

What does the generic name aminocaproic acid mean?

Aminocaproic acid is the generic name of the active substance in Minocap Injection. It belongs to a group of medicines called anti-fibrinolytic drugs, which help slow the breakdown of blood clots and so reduce bleeding.

How should Minocap Injection be stored?

Store it in a cool, dry place away from light, and keep it out of the reach of children. The suspension should be kept below 30°C. If you are unsure about storage conditions at home, ask your pharmacist for advice.

Is it safe in pregnancy or breastfeeding?

In pregnancy, it should be given only when clearly needed, and it is not known whether it can harm the baby or pass into breast milk. Pregnant or breastfeeding women should discuss the risks and benefits with their doctor before treatment.

Who should not receive Minocap Injection?

It should not be used when there is an active clotting process inside the blood vessels, and the reason for bleeding must be confirmed first. Tell the doctor about any medical conditions or other medicines, and ask them if you have concerns about receiving it.

Indications

Aminocaproic acid used to treat excessive postoperative bleeding, especially after procedures in which a great amount of bleeding is expected, such as cardiac surgery. It can be given orally or intravenously. A meta-analysis found that lysine analogs like Aminocaproic acid significantly reduced blood ... Read moreAminocaproic acid used to treat excessive postoperative bleeding, especially after procedures in which a great amount of bleeding is expected, such as cardiac surgery. It can be given orally or intravenously. A meta-analysis found that lysine analogs like Aminocaproic acid significantly reduced blood loss in patients undergoing coronary artery bypass grafting. Aminocaproic acid can also be used to treat the overdose and/or toxic effects of the thrombolytic pharmacologic agents tissue plasminogen activator and streptokinase.

Pharmacology

The fibrinolysis-inhibitory effects of Aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity.

Dosage & Administration

Dosage of  Aminocaproic acid must be adjusted to individual cases according to the severity of the hemmohagic event. It must however born in mind that Aminocaproic acid cleared rapidly by renal rough, so that administration must be repeated every 4-6 hours. The average dose is 8-16 gm a day.i.e. 1 ampule of Aminocaproic acid according to the case, every 6 hours.

Aminocaproic acid is equally effective by mouth and intarvenous injection. In cases of particular severity, or when it is sought to obtain a high blood concentration quickly it is advisable to start treatment by intravenous rough, with slow injection of two Aminocaproic acid ampules with an interval of 30-60 minutes between them, continuing with divided doses until a dosage of 20-25 grams in the 24 hour is reached.

In any case, administration of the drug must be continued until complete cessation of all symptoms. Aminocaproic acid could be intravenously administered, following suitable dilution in Physiological solution.

Contraindications

  • Aminocaproic acid should not be used when there is evidence of an active intravascular clotting process.
  • When there is uncertainty as to whether the cause of bleeding is primary fibrinolysis or disseminated intravascular coagulation (DIC), this distinction must be made before administering Aminocaproic acid Injection.
  • The following tests can be applied to differentiate the two conditions:
  • Platelet count is usually decreased in DIC but normal in primary fibrinolysis.
  • Protamine paracoagulation test is positive in DIC; a precipitate forms when protamine sulfate is dropped into citrated plasma. The test is negative in the presence of primary fibrinolysis.
  • The euglobulin clot lyses test is abnormal in primary fibrinolysis but normal in DIC.
  • Aminocaproic acid Injection must not be used in the presence of DIC without concomitant heparin.

Side Effects

Mild muscle pain or weakness; headache, tired feeling; nausea, vomiting, stomach pain, diarrhea; (in men) decreased amount of semen when having an orgasm; stuffy nose, watery eyes; vision problems, ringing in your ears; or Mild skin rash.

Pregnancy & Lactation

Pregnancy Category C. Animal reproduction studies have not been conducted with aminocaproic acid. It is also not known whether aminocaproic acid can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Aminocaproic Acid Injection should be given to a pregnant woman only if clearly needed.

Precautions & Warnings

Safety and efficacy have not been established in patients younger than 18 years.

Storage Conditions

Store in a cool, dry place, protected from light. Store the suspension below 30° C. Keep out of reach of children.

Alternative brands of Aminocaproic Acid

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.